Evidence map›Paper›PMID 10348752›Full record

ArticleAntimicrobial agents and chemotherapy1999

Serine protease inhibitors block invasion of host cells by Toxoplasma gondii.

V Conseil, M Soête, J F Dubremetz

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 91 citations in OpenAlex.

  1. Effects ofInfection and immunity · 2023
    Article
  2. Article
  3. Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Tropical medicine and infectious disease · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. [Characteristics of exosomes secreted byNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Activation of aFrontiers in microbiology · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. An atypical proprotein convertase in Giardia lamblia differentiation.Molecular and biochemical parasitology · 2011
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

V ConseilUnité 42 INSERM. IBL, Institut Pasteur de Lille, 59019 Lille Cedex, France.
M Soête
J F Dubremetz
Inserm · FRInstitut Pasteur de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the effect of protease inhibitors on the asexual development of the protozoan parasite Toxoplasma gondii. Among the inhibitors tested only two irreversible serine protease inhibitors, 3,4-dichloroisocoumarin and 4-(2-aminoethyl)-benzenesulfonyl fluoride, clearly prevented invasion of the host cells by specifically affecting parasite targets in a dose-dependent manner, with 50% inhibitory concentrations between 1 and 5 and 50 and 100 microM, respectively. Neither compound significantly affected parasite morphology, basic metabolism, or gliding motility within the range of the experimental conditions in which inhibition of invasion was demonstrated. No partial invasion was observed, meaning that inhibition occurred at an early stage of the interaction. These results suggest that at least one serine protease of the parasite is involved in the invasive process of T. gondii.

Indexed as

AnimalsChlorocebus aethiopsCoumarinsIsocoumarinsSerine EndopeptidasesSerine Proteinase InhibitorsSulfonesToxoplasmaVero Cells3,4-dichloroisocoumarin4-(2-aminoethyl)benzenesulfonylfluorideCoumarinsIsocoumarinsSerine EndopeptidasesSerine Proteinase InhibitorsSulfones

Identifiers

PMID10348752
PMCPMC89278
OpenAlexW2161457319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.